首页 > 最新文献

Journal of diabetes and its complications最新文献

英文 中文
Circulating CD31+ Angiogenic T cells are reduced in prediabetes and increase with exercise training
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-09-17 DOI: 10.1016/j.jdiacomp.2024.108868

Aims

To investigate circulating angiogenic cells in adults with prediabetes and the effect of a structured exercise program.

Methods

A cohort of adults with overweight/obesity and either normal glucose (NG) or prediabetes were randomised to receive exercise (Exercise) (as twice weekly supervised combined high intensity aerobic exercise and progressive resistance training, and once weekly home-based aerobic exercise) or an unsupervised stretching intervention (Control) for 12 weeks. Circulating angiogenic T cells, muscle strength, and cardiovascular disease risk factors, including blood lipids, arterial stiffness, central haemodynamic responses, and cardiorespiratory fitness (VO2peak) in those with prediabetes (n = 35, 16 Control, 19 Exercise) and NG (n = 37, 17 Control, 20 Exercise) were analysed at baseline and after the 12-week intervention.

Results

At baseline, compared with NG those with prediabetes demonstrated reduced VO2peak, angiogenic CD31+CD8+ T cells and VEGFR2+CD4+ T cells, and increased systolic blood pressure. CD31+ T cells were negatively correlated with cardiovascular disease (CVD) risk. Compared with Control, exercise training increased muscle strength, VO2peak, and CD31+CD4+ and CD31+CD8+ T cells in NG and prediabetes.

Conclusions

Circulating angiogenic CD31+ T cells are decreased in people with prediabetes and are enhanced with exercise training. Exercise increases CD31+ T cells, and through this mechanism it is proposed that it may reduce CVD risk.

Trial registration

Australian New Zealand Clinical Trials Registry number: ACTRN12617000552381.

方法将一组超重/肥胖、血糖正常(NG)或糖尿病前期的成年人随机分配到接受运动(运动)(每周两次有监督的高强度有氧运动和渐进阻力训练,每周一次在家进行有氧运动)或无监督拉伸干预(对照组)的人群中,为期 12 周。对糖尿病前期患者(n = 35,16 个对照组,19 个运动组)和 NG 患者(n = 37,17 个对照组,20 个运动组)在基线和 12 周干预后的循环血管生成 T 细胞、肌肉力量和心血管疾病风险因素(包括血脂、动脉僵化、中心血流动力学反应和心肺功能(VO2 峰值))进行分析。结果基线时,与 NG 相比,糖尿病前期患者的 VO2 峰值、血管生成 CD31+CD8+ T 细胞和 VEGFR2+CD4+ T 细胞均有所降低,收缩压也有所升高。CD31+ T细胞与心血管疾病(CVD)风险呈负相关。与对照组相比,运动训练可增加 NG 和糖尿病前期患者的肌力、VO2 峰值、CD31+CD4+ 和 CD31+CD8+ T 细胞。运动可增加 CD31+ T 细胞,通过这一机制,运动可降低心血管疾病风险:ACTRN12617000552381。
{"title":"Circulating CD31+ Angiogenic T cells are reduced in prediabetes and increase with exercise training","authors":"","doi":"10.1016/j.jdiacomp.2024.108868","DOIUrl":"10.1016/j.jdiacomp.2024.108868","url":null,"abstract":"<div><h3>Aims</h3><p>To investigate circulating angiogenic cells in adults with prediabetes and the effect of a structured exercise program.</p></div><div><h3>Methods</h3><p>A cohort of adults with overweight/obesity and either normal glucose (NG) or prediabetes were randomised to receive exercise (Exercise) (as twice weekly supervised combined high intensity aerobic exercise and progressive resistance training, and once weekly home-based aerobic exercise) or an unsupervised stretching intervention (Control) for 12 weeks. Circulating angiogenic T cells, muscle strength, and cardiovascular disease risk factors, including blood lipids, arterial stiffness, central haemodynamic responses, and cardiorespiratory fitness (VO<sub>2</sub>peak) in those with prediabetes (<em>n</em> = 35, 16 Control, 19 Exercise) and NG (<em>n</em> = 37, 17 Control, 20 Exercise) were analysed at baseline and after the 12-week intervention.</p></div><div><h3>Results</h3><p>At baseline, compared with NG those with prediabetes demonstrated reduced VO<sub>2</sub>peak, angiogenic CD31<sup>+</sup>CD8<sup>+</sup> T cells and VEGFR2<sup>+</sup>CD4<sup>+</sup> T cells, and increased systolic blood pressure. CD31<sup>+</sup> T cells were negatively correlated with cardiovascular disease (CVD) risk. Compared with Control, exercise training increased muscle strength, VO<sub>2</sub>peak, and CD31<sup>+</sup>CD4<sup>+</sup> and CD31<sup>+</sup>CD8<sup>+</sup> T cells in NG and prediabetes.</p></div><div><h3>Conclusions</h3><p>Circulating angiogenic CD31<sup>+</sup> T cells are decreased in people with prediabetes and are enhanced with exercise training. Exercise increases CD31<sup>+</sup> T cells, and through this mechanism it is proposed that it may reduce CVD risk.</p></div><div><h3>Trial registration</h3><p>Australian New Zealand Clinical Trials Registry number: ACTRN12617000552381.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142241137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonists
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-09-17 DOI: 10.1016/j.jdiacomp.2024.108872
{"title":"Emerging treatment strategies for polycystic ovary syndrome women with obesity: Focus on glucagon-like peptide-1 receptor agonists","authors":"","doi":"10.1016/j.jdiacomp.2024.108872","DOIUrl":"10.1016/j.jdiacomp.2024.108872","url":null,"abstract":"","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1056872724001983/pdfft?md5=bf59c2d5346189bde536705d66936189&pid=1-s2.0-S1056872724001983-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142241136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contents/Barcode 内容/条形码
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-09-09 DOI: 10.1016/S1056-8727(24)00185-5
{"title":"Contents/Barcode","authors":"","doi":"10.1016/S1056-8727(24)00185-5","DOIUrl":"10.1016/S1056-8727(24)00185-5","url":null,"abstract":"","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1056872724001855/pdfft?md5=d067c4de3b819fb03a4ed850e9729b85&pid=1-s2.0-S1056872724001855-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142163121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The inter-relationship between Helicobacter pylori infection, dementia and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase I 幽门螺杆菌感染、痴呆症和 2 型糖尿病患者死亡率之间的相互关系:弗里曼特尔糖尿病研究第一阶段
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-09-05 DOI: 10.1016/j.jdiacomp.2024.108854

Background

Given sparse relevant data, the aim of this study was to determine whether Helicobacter pylori infection, including cytotoxin-associated gene-A (CagA) producing strains, is associated with dementia in type 2 diabetes (T2DM).

Methods

Longitudinal data from 1115 participants in the community-based Fremantle Diabetes Study Phase I (mean age 64.0 years, 48.0 % males; 38.0 % H. pylori seronegative, 24.3 % H. pylori seropositive/CagA seronegative, and 37.7 % H. pylori/CagA seropositive at baseline) were analyzed.

Results

During up to 19 years of follow-up, 50.3 % and 83.5 % of participants without and with incident dementia, respectively, died. In Cox proportional hazards models, H. pylori/CagA seropositivity (hazard ratio (95 % CI) 1.68 (1.15, 2.46), P = 0.008), but not H. pylori seropositivity/CagA seronegativity (P = 0.541) was an independent predictor of incident dementia, but neither H. pylori seropositivity/CagA seronegativity nor H. pylori/CagA seropositivity were significant predictors in competing risks models (P ≥ 0.280).

Conclusions

Although CagA seropositivity in T2DM may have a contributory etiologic role in the risk of dementia, this may be through its association with reduced cardiovascular/all-cause mortality.

背景鉴于相关数据稀少,本研究旨在确定幽门螺杆菌感染(包括产生细胞毒素相关基因-A(CagA)的菌株)是否与 2 型糖尿病(T2DM)患者的痴呆症有关。结果在长达 19 年的随访中,分别有 50.3% 和 83.5% 的未患痴呆症和患痴呆症的参与者死亡。在Cox比例危险模型中,幽门螺杆菌/CagA血清阳性(危险比 (95 % CI) 1.68 (1.15, 2.46),P = 0.008),而不是幽门螺杆菌/CagA血清阴性(P = 0.541)是痴呆症的独立预测因素,但幽门螺杆菌/CagA血清阳性和幽门螺杆菌/CagA血清阴性均不是痴呆症的独立预测因素。结论尽管T2DM患者的CagA血清阳性可能对痴呆风险有一定的病因学作用,但这可能是通过其与心血管/全因死亡率降低的关系实现的。
{"title":"The inter-relationship between Helicobacter pylori infection, dementia and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase I","authors":"","doi":"10.1016/j.jdiacomp.2024.108854","DOIUrl":"10.1016/j.jdiacomp.2024.108854","url":null,"abstract":"<div><h3>Background</h3><p>Given sparse relevant data, the aim of this study was to determine whether <em>Helicobacter pylori</em> infection, including cytotoxin-associated gene-A (CagA) producing strains, is associated with dementia in type 2 diabetes (T2DM).</p></div><div><h3>Methods</h3><p>Longitudinal data from 1115 participants in the community-based Fremantle Diabetes Study Phase I (mean age 64.0 years, 48.0 % males; 38.0 % <em>H. pylori</em> seronegative, 24.3 % <em>H. pylori</em> seropositive/CagA seronegative, and 37.7 % <em>H. pylori</em>/CagA seropositive at baseline) were analyzed.</p></div><div><h3>Results</h3><p>During up to 19 years of follow-up, 50.3 % and 83.5 % of participants without and with incident dementia, respectively, died. In Cox proportional hazards models, <em>H. pylori</em>/CagA seropositivity (hazard ratio (95 % CI) 1.68 (1.15, 2.46), <em>P</em> = 0.008), but not <em>H. pylori</em> seropositivity/CagA seronegativity (<em>P</em> = 0.541) was an independent predictor of incident dementia, but neither <em>H. pylori</em> seropositivity/CagA seronegativity nor <em>H. pylori</em>/CagA seropositivity were significant predictors in competing risks models (<em>P</em> ≥ 0.280).</p></div><div><h3>Conclusions</h3><p>Although CagA seropositivity in T2DM may have a contributory etiologic role in the risk of dementia, this may be through its association with reduced cardiovascular/all-cause mortality.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1056872724001806/pdfft?md5=fbebd4a96986440b0e993c6aff90ce7f&pid=1-s2.0-S1056872724001806-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142150376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary counseling, meal patterns, and diet quality in patients with type 2 diabetes mellitus with/without chronic kidney disease 伴有/不伴有慢性肾病的 2 型糖尿病患者的饮食咨询、膳食模式和饮食质量。
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-09-03 DOI: 10.1016/j.jdiacomp.2024.108853

Background

Aim to this study is to investigate the association of Dietary Counseling, Meal Patterns, and Diet Quality (DietQ) in Patients with Type 2 Diabetes Mellitus (T2DM) with/without chronic kidney disease (CKD) in primary healthcare.

Methods

Cross-sectional study acquired data on dietary counseling and meal patterns by direct interview with a food-frequency questionnaire and one 24-h food-recall. The Healthy Eating Index (HEI) was used to classify DietQ [“good” DietQ (GDietQ, score ≥ 80) and “poor” DietQ (PDietQ, score < 80)].

Participants/setting

This study included 705 patients with T2DM: 306 with normal kidney function; 236 with early nephropathy, and 163 with overt nephropathy (ON).

Statistical analyses performed

Multivariate linear-regression models for predicting HEI and χ2 tests for qualitative variables and one-way ANOVA for quantitative variables were employed. Mann-Whitney U and independent Student t were performed for comparisons between GDietQ and PDietQ.

Results

Only 18 % of the population was classified as GDietQ. Patients with ON and PDietQ vs. with GDietQ received significantly less dietary counseling from any health professional in general (45 % vs 72 %, respectively), or from any nutrition professional (36 % vs. 61 %, respectively). A better HEI was significantly predicted (F = 42.01; p = 0.0001) by lower HbA1C (β −0.53, p = 0.0007) and better diet diversity (β 8.09, p = 0.0001).

Conclusions

Patients with more advanced stages of CKD had less nutritional counseling and worse dietary patterns, as well as more frequent PDietQ. Our findings reinforce the need for dietitians and nutritionists in primary healthcare to provide timely nutritional counseling.

研究背景本研究旨在调查基层医疗机构中患有/未患有慢性肾脏病(CKD)的2型糖尿病(T2DM)患者的饮食咨询、膳食模式和饮食质量(DietQ)之间的关联:方法:横断面研究通过食物频率问卷直接访谈和一次 24 小时食物回忆,获得有关饮食咨询和膳食模式的数据。采用健康饮食指数(HEI)对饮食质量进行分类["好 "饮食质量(GDietQ,得分≥80)和 "差 "饮食质量(PDietQ,得分 参与者/设置:该研究包括 705 名 T2DM 患者:306 名肾功能正常者;236 名早期肾病患者和 163 名明显肾病患者(ON):采用多变量线性回归模型预测 HEI,对定性变量进行 χ2 检验,对定量变量进行单因素方差分析。在比较 GDietQ 和 PDietQ 时,采用 Mann-Whitney U 和独立 Student t:结果:只有 18% 的人被归类为 GDietQ。ON和PDietQ患者与GDietQ患者相比,从一般医疗专业人员(分别为45%和72%)或营养专业人员(分别为36%和61%)那里获得的饮食咨询明显较少。较低的 HbA1C(β -0.53,p = 0.0007)和较好的饮食多样性(β 8.09,p = 0.0001)可明显预测较好的 HEI(F = 42.01;p = 0.0001):结论:慢性肾脏病晚期患者的营养咨询较少,饮食模式较差,PDietQ 发生率较高。我们的研究结果强化了营养师和营养学家在初级医疗保健中提供及时营养咨询的必要性。
{"title":"Dietary counseling, meal patterns, and diet quality in patients with type 2 diabetes mellitus with/without chronic kidney disease","authors":"","doi":"10.1016/j.jdiacomp.2024.108853","DOIUrl":"10.1016/j.jdiacomp.2024.108853","url":null,"abstract":"<div><h3>Background</h3><p>Aim to this study is to investigate the association of Dietary Counseling, Meal Patterns, and Diet Quality (DietQ) in Patients with Type 2 Diabetes Mellitus (T2DM) with/without chronic kidney disease (CKD) in primary healthcare.</p></div><div><h3>Methods</h3><p>Cross-sectional study acquired data on dietary counseling and meal patterns by direct interview with a food-frequency questionnaire and one 24-h food-recall. The Healthy Eating Index (HEI) was used to classify DietQ [“good” DietQ (GDietQ, score ≥ 80) and “poor” DietQ (PDietQ, score &lt; 80)].</p></div><div><h3>Participants/setting</h3><p>This study included 705 patients with T2DM: 306 with normal kidney function; 236 with early nephropathy, and 163 with overt nephropathy (ON).</p></div><div><h3>Statistical analyses performed</h3><p>Multivariate linear-regression models for predicting HEI and χ<sup>2</sup> tests for qualitative variables and one-way ANOVA for quantitative variables were employed. Mann-Whitney U and independent Student t were performed for comparisons between GDietQ and PDietQ.</p></div><div><h3>Results</h3><p>Only 18 % of the population was classified as GDietQ. Patients with ON and PDietQ <em>vs.</em> with GDietQ received significantly less dietary counseling from any health professional in general (45 % <em>vs</em> 72 %, respectively), or from any nutrition professional (36 % <em>vs.</em> 61 %, respectively). A better HEI was significantly predicted (F = 42.01; <em>p</em> = 0.0001) by lower HbA<sub>1C</sub> (β −0.53, <em>p</em> = 0.0007) and better diet diversity (β 8.09, <em>p</em> = 0.0001).</p></div><div><h3>Conclusions</h3><p>Patients with more advanced stages of CKD had less nutritional counseling and worse dietary patterns, as well as more frequent PDietQ. Our findings reinforce the need for dietitians and nutritionists in primary healthcare to provide timely nutritional counseling.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142143085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Too good to be true: Are GLP-1 receptor agonists the new metformin? 好得不像真的GLP-1 受体激动剂是新的二甲双胍吗?
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-08-30 DOI: 10.1016/j.jdiacomp.2024.108851

Recently, a health-care database study showed that persons with type 2 diabetes taking GLP-1 receptor agonists (GLP-1 RA) had a significantly lower risk of 10 out of 13 obesity-related cancers than patients taking insulin (Wang L, et al. JAMA Netw Open. 2024 7: e2421305). For some cancers, hazard ratios <0.5 were reported. This is reminiscent of studies published >10 years ago showing that people with type 2 diabetes taking metformin had a lower risk of many types of cancer than those not taking metformin. In some studies, also risk reductions of >50 % were reported.

The strong effects observed in the metformin studies were explained by time-related biases, in particular, immortal time bias. In the current GLP-1 RA study, it was striking that the curves for the cumulative incidence of several cancers in GLP-1 RA and insulin users diverged immediately after therapy onset. This indicates that there is most likely a time-related bias: insulin is given at much later stages of type 2 diabetes than GLP-1 RA.

The current study suggests that one should be sceptical about database results when spectacular risk reductions are reported. Time-related bias should always be considered as an alternative explanation.

最近,一项医疗保健数据库研究显示,与服用胰岛素的患者相比,服用 GLP-1 受体激动剂(GLP-1 RA)的 2 型糖尿病患者罹患 13 种肥胖相关癌症中的 10 种的风险明显较低(Wang L 等,JAMA Netw Open. 2024 7: e2421305)。据报道,某些癌症的危险比为 0.5。这不禁让人想起 10 年前发表的研究>,这些研究显示,服用二甲双胍的 2 型糖尿病患者罹患多种癌症的风险低于未服用二甲双胍的患者。在一些研究中,风险还降低了50%。二甲双胍研究中观察到的强烈效应可以用与时间相关的偏差来解释,特别是不朽时间偏差。在目前的 GLP-1 RA 研究中,令人惊讶的是,GLP-1 RA 和胰岛素使用者的几种癌症累积发病率曲线在治疗开始后立即出现了分叉。这表明很可能存在与时间相关的偏差:与 GLP-1 RA 相比,胰岛素在 2 型糖尿病更晚的阶段才开始使用。与时间有关的偏差应始终被视为一种替代解释。
{"title":"Too good to be true: Are GLP-1 receptor agonists the new metformin?","authors":"","doi":"10.1016/j.jdiacomp.2024.108851","DOIUrl":"10.1016/j.jdiacomp.2024.108851","url":null,"abstract":"<div><p>Recently, a health-care database study showed that persons with type 2 diabetes taking GLP-1 receptor agonists (GLP-1 RA) had a significantly lower risk of 10 out of 13 obesity-related cancers than patients taking insulin (Wang L, et al. JAMA Netw Open. 2024 7: e2421305). For some cancers, hazard ratios &lt;0.5 were reported. This is reminiscent of studies published &gt;10 years ago showing that people with type 2 diabetes taking metformin had a lower risk of many types of cancer than those not taking metformin. In some studies, also risk reductions of &gt;50 % were reported.</p><p>The strong effects observed in the metformin studies were explained by time-related biases, in particular, immortal time bias. In the current GLP-1 RA study, it was striking that the curves for the cumulative incidence of several cancers in GLP-1 RA and insulin users diverged immediately after therapy onset. This indicates that there is most likely a time-related bias: insulin is given at much later stages of type 2 diabetes than GLP-1 RA.</p><p>The current study suggests that one should be sceptical about database results when spectacular risk reductions are reported. Time-related bias should always be considered as an alternative explanation.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography 利用 OCT 血管造影术对糖尿病患者视网膜微血管变化的性别分析
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-08-28 DOI: 10.1016/j.jdiacomp.2024.108852

Purpose

To assess the difference in microvascular changes between males and females with diabetes mellitus (DM) without diabetic retinopathy (NoDR) and with mild-to-moderate non-proliferative diabetic retinopathy (NPDR) using Optical Coherence Tomography Angiography (OCT-A).

Design

Retrospective cross-sectional study.

Methods

267 DM patients, 133 females (49.81 %), 111 with NoDR (41.57 %) and 156 NPDR (58.43 %) were included. Foveal-centered 3 × 3 mm OCT-A images corresponding to the superficial (SCP), intermediate (ICP) and deep capillary plexus (DCP), and full retinal (RET) slab were used for analysis. For each slab, FAZ area, perimeter, and circularity index (CI) were determined, following manual delineation of the FAZ; perfusion (PD) and vessel density (VD), fractal dimension (FD), vessel length density (VLD), geometric perfusion deficits (GPD) were also computed. Flow voids (FV) were determined in the choriocapillaris plexus; and perfused capillary density (PCD) in the RET slab.

Results

Females showed larger FAZ CI in SCP and greater FAZ area and perimeter than males in NPDR group. Males had higher central macular thickness than females in NPDR group. All density metrics at the level of ICP and DCP were affected in the NPDR group with no gender differences. Of note, the same significant findings were found in type 1 DM patients, and not in type 2 DM patients.

Conclusions

Our OCT-A findings suggest significant microvascular changes in females with NPDR compared to males, but no such differences in patients without DR. Therefore, gender-related vascular alterations might be present in early stages of DR with potential role.

目的 使用光学相干断层扫描血管造影术(OCT-A)评估无糖尿病视网膜病变(NoDR)和轻度至中度非增生性糖尿病视网膜病变(NPDR)男性和女性患者之间微血管变化的差异。分析采用了以眼窝为中心的 3 × 3 mm OCT-A 图像,分别对应浅层毛细血管丛(SCP)、中间层毛细血管丛(ICP)、深层毛细血管丛(DCP)和全视网膜(RET)板块。人工划定视网膜浅层(FAZ)后,确定每块视网膜板块的视网膜浅层(FAZ)面积、周长和圆度指数(CI);还计算了灌注(PD)和血管密度(VD)、分形维度(FD)、血管长度密度(VLD)、几何灌注缺损(GPD)。结果女性在SCP中显示出更大的FAZ CI,在NPDR组中显示出比男性更大的FAZ面积和周长。NPDR组男性的黄斑中心厚度高于女性。NPDR 组在 ICP 和 DCP 水平上的所有密度指标均受到影响,但无性别差异。结论我们的 OCT-A 发现表明,与男性相比,女性 NPDR 患者的微血管发生了显著变化,但在非 DR 患者中却没有这种差异。因此,与性别相关的血管改变可能存在于 DR 的早期阶段,并具有潜在的作用。
{"title":"A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography","authors":"","doi":"10.1016/j.jdiacomp.2024.108852","DOIUrl":"10.1016/j.jdiacomp.2024.108852","url":null,"abstract":"<div><h3>Purpose</h3><p>To assess the difference in microvascular changes between males and females with diabetes mellitus (DM) without diabetic retinopathy (NoDR) and with mild-to-moderate non-proliferative diabetic retinopathy (NPDR) using Optical Coherence Tomography Angiography (OCT-A).</p></div><div><h3>Design</h3><p>Retrospective cross-sectional study.</p></div><div><h3>Methods</h3><p>267 DM patients, 133 females (49.81 %), 111 with NoDR (41.57 %) and 156 NPDR (58.43 %) were included. Foveal-centered 3 × 3 mm OCT-A images corresponding to the superficial (SCP), intermediate (ICP) and deep capillary plexus (DCP), and full retinal (RET) slab were used for analysis. For each slab, FAZ area, perimeter, and circularity index (CI) were determined, following manual delineation of the FAZ; perfusion (PD) and vessel density (VD), fractal dimension (FD), vessel length density (VLD), geometric perfusion deficits (GPD) were also computed. Flow voids (FV) were determined in the choriocapillaris plexus; and perfused capillary density (PCD) in the RET slab.</p></div><div><h3>Results</h3><p>Females showed larger FAZ CI in SCP and greater FAZ area and perimeter than males in NPDR group. Males had higher central macular thickness than females in NPDR group. All density metrics at the level of ICP and DCP were affected in the NPDR group with no gender differences. Of note, the same significant findings were found in type 1 DM patients, and not in type 2 DM patients.</p></div><div><h3>Conclusions</h3><p>Our OCT-A findings suggest significant microvascular changes in females with NPDR compared to males, but no such differences in patients without DR. Therefore, gender-related vascular alterations might be present in early stages of DR with potential role.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142095091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes 患有或未患有 2 型糖尿病的急性心肌梗死患者的新型致动脉粥样硬化指数的预后价值
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-08-24 DOI: 10.1016/j.jdiacomp.2024.108850

Aims

Atherogenic indices: Triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, Atherogenic Index of Plasma (AIP), Atherogenic Coefficient (AC), Castelli's Risk Index I and II (CRI-I, CRI-II) are used in clinical studies as surrogates of major adverse cardiac and cerebrovascular events (MACCE). Risk prediction of MACCE in patients with acute myocardial infarction (AMI) has vital role in clinical practice. We aimed to assess prognostic value of these indices following AMI.

Methods

We analyzed patients with AMI with and without T2DM and the prognostic values of atherogenic indices for in-hospital death and MACCE within 12 months after AMI.

Results

Of 2461 patients, 152 in-hospital deaths (6.2 %) were reported (74 patients [7.4 %] with T2DM and 78 [5.3 %] without T2DM; p = 0.042). MACCE occurred in 22.7 % of patients (29.7 % with T2DM and 17.9 % without T2DM; p < 0.001). TG/HDL-C and AIP were higher in T2DM patients compared to those without T2DM (p < 0.001). Long-term MACCE was more prevalent in patients with T2DM (p < 0.001). The AUC-ROC for predicting in-hospital death based on TG/HDL-C and AIP was 0.57 (p = 0.002).

Conclusions

None of the atherogenic indices was an independent risk factor for in-hospital death or MACCE at 12-month follow-up in patients with AMI. AIP was an independent risk factor for death at 12-month follow-up.

目的致动脉粥样硬化指数:在临床研究中,甘油三酯与高密度脂蛋白胆固醇(TG/HDL-C)比值、血浆致动脉粥样硬化指数(AIP)、致动脉粥样硬化系数(AC)、卡斯泰利风险指数 I 和 II(CRI-I、CRI-II)被用作重大心脏和脑血管不良事件(MACCE)的替代指标。对急性心肌梗死(AMI)患者的主要不良心脑血管事件进行风险预测在临床实践中具有重要作用。我们分析了有 T2DM 和无 T2DM 的急性心肌梗死患者,以及动脉粥样硬化指数对急性心肌梗死后 12 个月内院内死亡和 MACCE 的预后价值。结果 在 2461 名患者中,有 152 人(6.2%)在院内死亡(74 名患者[7.4%]有 T2DM,78 名患者[5.3%]无 T2DM;P = 0.042)。22.7%的患者发生了 MACCE(T2DM 患者为 29.7%,非 T2DM 患者为 17.9%;P = 0.001)。与非 T2DM 患者相比,T2DM 患者的 TG/HDL-C 和 AIP 更高(p <0.001)。T2DM 患者的长期澳门巴黎人娱乐官网发生率更高(p < 0.001)。结论在随访 12 个月的 AMI 患者中,没有一个致动脉粥样硬化指数是院内死亡或 MACCE 的独立危险因素。AIP是随访12个月时死亡的独立风险因素。
{"title":"Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes","authors":"","doi":"10.1016/j.jdiacomp.2024.108850","DOIUrl":"10.1016/j.jdiacomp.2024.108850","url":null,"abstract":"<div><h3>Aims</h3><p>Atherogenic indices: Triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, Atherogenic Index of Plasma (AIP), Atherogenic Coefficient (AC), Castelli's Risk Index I and II (CRI-I, CRI-II) are used in clinical studies as surrogates of major adverse cardiac and cerebrovascular events (MACCE). Risk prediction of MACCE in patients with acute myocardial infarction (AMI) has vital role in clinical practice. We aimed to assess prognostic value of these indices following AMI.</p></div><div><h3>Methods</h3><p>We analyzed patients with AMI with and without T2DM and the prognostic values of atherogenic indices for in-hospital death and MACCE within 12 months after AMI.</p></div><div><h3>Results</h3><p>Of 2461 patients, 152 in-hospital deaths (6.2 %) were reported (74 patients [7.4 %] with T2DM and 78 [5.3 %] without T2DM; <em>p</em> = 0.042). MACCE occurred in 22.7 % of patients (29.7 % with T2DM and 17.9 % without T2DM; <em>p</em> &lt; 0.001). TG/HDL-C and AIP were higher in T2DM patients compared to those without T2DM (<em>p</em> &lt; 0.001). Long-term MACCE was more prevalent in patients with T2DM (p &lt; 0.001). The AUC-ROC for predicting in-hospital death based on TG/HDL-C and AIP was 0.57 (<em>p</em> = 0.002).</p></div><div><h3>Conclusions</h3><p>None of the atherogenic indices was an independent risk factor for in-hospital death or MACCE at 12-month follow-up in patients with AMI. AIP was an independent risk factor for death at 12-month follow-up.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1056872724001764/pdfft?md5=6bda50d070c82f5ff190d5866b000151&pid=1-s2.0-S1056872724001764-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142076987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age at onset of type 2 diabetes and prevalence of vascular disease and heart failure: Systematic review and dose-response meta-analysis 2 型糖尿病的发病年龄与血管疾病和心力衰竭的患病率:系统回顾和剂量反应荟萃分析
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-08-22 DOI: 10.1016/j.jdiacomp.2024.108849

Aim

To investigate the relationship between age at diagnosis of type 2 diabetes and the risk of macrovascular disease, heart failure, and microvascular disease.

Methods

In August 2022, PubMed/EMBASE were searched for articles reporting (i) coronary artery disease, cerebrovascular disease, peripheral vascular disease, amputation; (ii) heart failure; and (iii) retinopathy, neuropathy, nephropathy (albuminuria, chronic kidney disease [CKD], end-stage renal disease) by age at diagnosis of type 2 diabetes. Random effects, non-linear dose-response meta-analysis was undertaken for each outcome to assess the association with age at diagnosis (40 years = reference), using both crude and maximally adjusted odds ratios separately, with and without adjustment for current age (age at sampling).

Results

We identified 42 articles (230,003 to 3,465,590 participants; 1035 to 391,140 events). Age at diagnosis was positively associated with the risk of macrovascular diseases, heart failure, and CKD, independent of current age, and negatively associated with retinopathy. For other microvascular outcomes, when adjusting for current age, a “reverse U" relationship was observed (peak risk = 55–60 years).

Discussion

Retinopathy was negatively associated with age at diagnosis, highlighting the importance of retinopathy screening in early-onset type 2 diabetes. The implications of other associations were unclear due to the heterogeneity in methodologies and findings.

目的研究确诊2型糖尿病的年龄与罹患大血管疾病、心力衰竭和微血管疾病风险之间的关系。方法2022年8月,在PubMed/EMBASE数据库中检索了根据2型糖尿病诊断年龄报告(i)冠状动脉疾病、脑血管疾病、外周血管疾病、截肢;(ii)心力衰竭;(iii)视网膜病变、神经病变、肾病(白蛋白尿、慢性肾病[CKD]、终末期肾病)的文章。对每种结果都进行了随机效应、非线性剂量-反应荟萃分析,以评估与诊断时年龄(40 岁 = 参考)的关系,分别使用粗略和最大调整的几率,并对当前年龄(采样时年龄)进行调整和不进行调整。诊断时的年龄与大血管疾病、心力衰竭和慢性肾脏病的风险呈正相关,与当前年龄无关,而与视网膜病变呈负相关。讨论视网膜病变与确诊年龄呈负相关,突出了视网膜病变筛查在早发二型糖尿病中的重要性。由于研究方法和结果的异质性,其他关联的影响尚不明确。
{"title":"Age at onset of type 2 diabetes and prevalence of vascular disease and heart failure: Systematic review and dose-response meta-analysis","authors":"","doi":"10.1016/j.jdiacomp.2024.108849","DOIUrl":"10.1016/j.jdiacomp.2024.108849","url":null,"abstract":"<div><h3>Aim</h3><p>To investigate the relationship between age at diagnosis of type 2 diabetes and the risk of macrovascular disease, heart failure, and microvascular disease.</p></div><div><h3>Methods</h3><p>In August 2022, PubMed/EMBASE were searched for articles reporting (i) coronary artery disease, cerebrovascular disease, peripheral vascular disease, amputation; (ii) heart failure; and (iii) retinopathy, neuropathy, nephropathy (albuminuria, chronic kidney disease [CKD], end-stage renal disease) by age at diagnosis of type 2 diabetes. Random effects, non-linear dose-response meta-analysis was undertaken for each outcome to assess the association with age at diagnosis (40 years = reference), using both crude and maximally adjusted odds ratios separately, with and without adjustment for current age (age at sampling).</p></div><div><h3>Results</h3><p>We identified 42 articles (230,003 to 3,465,590 participants; 1035 to 391,140 events). Age at diagnosis was positively associated with the risk of macrovascular diseases, heart failure, and CKD, independent of current age, and negatively associated with retinopathy. For other microvascular outcomes, when adjusting for current age, a “reverse U\" relationship was observed (peak risk = 55–60 years).</p></div><div><h3>Discussion</h3><p>Retinopathy was negatively associated with age at diagnosis, highlighting the importance of retinopathy screening in early-onset type 2 diabetes. The implications of other associations were unclear due to the heterogeneity in methodologies and findings.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1056872724001752/pdfft?md5=d1352b60b8393b7b5102b3a8eaa9149b&pid=1-s2.0-S1056872724001752-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142095090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis 糖尿病心肌病功能障碍的机理和治疗策略:聚焦热蛋白沉积
IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-08-20 DOI: 10.1016/j.jdiacomp.2024.108848

Diabetes is a major risk factor for cardiovascular diseases, and myocardial damage caused by hyperglycemia is the main cause of heart failure. However, there is still a lack of systematic understanding of myocardial damage caused by diabetes. At present, we believe that the cellular inflammatory damage caused by hyperglycemia is one of the causes of diabetic cardiomyopathy. Pyroptosis, as a proinflammatory form of cell death, is closely related to the occurrence and development of diabetic cardiomyopathy. Therefore, this paper focuses on the important role of inflammation in the occurrence and development of diabetic cardiomyopathy. From the perspective of pyroptosis, we summarize the pyroptosis of different types of cells in diabetic cardiomyopathy and its related signaling pathways. It also summarizes the treatment of diabetic cardiomyopathy, hoping to provide methods for the prevention and treatment of diabetic cardiomyopathy by inhibiting pyroptosis.

糖尿病是心血管疾病的主要危险因素,而高血糖引起的心肌损伤是心力衰竭的主要原因。然而,人们对糖尿病引起的心肌损伤仍缺乏系统的认识。目前,我们认为高血糖引起的细胞炎症损伤是糖尿病心肌病的病因之一。裂解病作为细胞死亡的一种促炎形式,与糖尿病心肌病的发生和发展密切相关。因此,本文重点探讨炎症在糖尿病心肌病发生和发展中的重要作用。从热凋亡的角度,总结了糖尿病心肌病中不同类型细胞的热凋亡及其相关信号通路。同时总结了糖尿病心肌病的治疗方法,希望为通过抑制热蛋白沉积预防和治疗糖尿病心肌病提供方法。
{"title":"The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis","authors":"","doi":"10.1016/j.jdiacomp.2024.108848","DOIUrl":"10.1016/j.jdiacomp.2024.108848","url":null,"abstract":"<div><p>Diabetes is a major risk factor for cardiovascular diseases, and myocardial damage caused by hyperglycemia is the main cause of heart failure. However, there is still a lack of systematic understanding of myocardial damage caused by diabetes. At present, we believe that the cellular inflammatory damage caused by hyperglycemia is one of the causes of diabetic cardiomyopathy. Pyroptosis, as a proinflammatory form of cell death, is closely related to the occurrence and development of diabetic cardiomyopathy. Therefore, this paper focuses on the important role of inflammation in the occurrence and development of diabetic cardiomyopathy. From the perspective of pyroptosis, we summarize the pyroptosis of different types of cells in diabetic cardiomyopathy and its related signaling pathways. It also summarizes the treatment of diabetic cardiomyopathy, hoping to provide methods for the prevention and treatment of diabetic cardiomyopathy by inhibiting pyroptosis.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142041202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of diabetes and its complications
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1